These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16116033)

  • 1. Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.
    Anlauf M; Schäfer MK; Schwark T; von Wurmb-Schwark N; Brand V; Sipos B; Horny HP; Parwaresch R; Hartschuh W; Eiden LE; Klöppel G; Weihe E
    J Histochem Cytochem; 2006 Feb; 54(2):201-13. PubMed ID: 16116033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.
    Anlauf M; Schafer MK; Depboylu C; Hartschuh W; Eiden LE; Kloppel G; Weihe E
    J Histochem Cytochem; 2004 Jun; 52(6):779-88. PubMed ID: 15150286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma.
    Graff L; Castrop F; Bauer M; Höfler H; Gratzl M
    Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia.
    Fukuda T; Kamishima T; Tsuura Y; Suzuki T; Kakihara T; Naito M; Kishi K; Matsumoto K; Shibata A; Seito T
    J Pathol; 1995 Oct; 177(2):139-46. PubMed ID: 7490680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors.
    Anlauf M; Eissele R; Schäfer MK; Eiden LE; Arnold R; Pauser U; Klöppel G; Weihe E
    J Histochem Cytochem; 2003 Aug; 51(8):1027-40. PubMed ID: 12871984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ; Brenn T; Hornick JL
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
    Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR
    Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
    Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
    J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
    Krauth MT; Agis H; Aichberger KJ; Simonitsch-Klupp I; Müllauer L; Mayerhofer M; Böhm A; Horny HP; Valent P
    Hum Pathol; 2006 Apr; 37(4):439-47. PubMed ID: 16564918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
    Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
    Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
    Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
    J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
    Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P
    Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
    Yao J; Erickson JD; Hersh LB
    Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.